Amphastar Pharmaceuticals ROA 2012-2024 | AMPH

Current and historical return on assets (ROA) values for Amphastar Pharmaceuticals (AMPH) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Amphastar Pharmaceuticals ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2024-09-30 $0.16B $1.55B 10.25%
2024-06-30 $0.17B $1.49B 10.84%
2024-03-31 $0.15B $1.57B 10.25%
2023-12-31 $0.14B $1.51B 10.52%
2023-09-30 $0.14B $1.55B 12.16%
2023-06-30 $0.10B $1.38B 11.27%
2023-03-31 $0.09B $0.77B 12.54%
2022-12-31 $0.09B $0.74B 12.51%
2022-09-30 $0.08B $0.73B 10.85%
2022-06-30 $0.09B $0.72B 13.17%
2022-03-31 $0.08B $0.72B 12.12%
2021-12-31 $0.06B $0.67B 9.56%
2021-09-30 $0.04B $0.65B 5.70%
2021-06-30 $0.01B $0.67B 1.72%
2021-03-31 $0.00B $0.65B 0.48%
2020-12-31 $0.00B $0.63B 0.33%
2020-09-30 $0.01B $0.61B 1.18%
2020-06-30 $0.00B $0.60B 0.68%
2020-03-31 $0.05B $0.57B 8.86%
2019-12-31 $0.05B $0.59B 8.45%
2019-09-30 $0.05B $0.59B 9.26%
2019-06-30 $0.05B $0.60B 9.90%
2019-03-31 $0.00B $0.55B 0.40%
2018-12-31 $-0.01B $0.51B -1.27%
2018-09-30 $-0.01B $0.48B -1.53%
2018-06-30 $-0.01B $0.45B -2.01%
2018-03-31 $-0.00B $0.45B -0.90%
2017-12-31 $0.00B $0.45B 0.90%
2017-09-30 $0.00B $0.44B 0.00%
2017-06-30 $0.00B $0.44B 0.92%
2017-03-31 $0.01B $0.44B 2.12%
2016-12-31 $0.01B $0.43B 2.41%
2016-09-30 $0.02B $0.43B 5.18%
2016-06-30 $0.01B $0.41B 3.52%
2016-03-31 $0.00B $0.40B 0.00%
2015-12-31 $-0.00B $0.39B -0.76%
2015-09-30 $-0.01B $0.40B -3.54%
2015-06-30 $-0.02B $0.40B -4.04%
2015-03-31 $-0.01B $0.40B -2.53%
2014-12-31 $-0.01B $0.39B -2.87%
2014-09-30 $-0.01B $0.40B -1.62%
2014-06-30 $-0.00B $0.40B -0.37%
2014-03-31 $0.01B $0.35B 4.68%
2013-12-31 $0.01B $0.34B 14.16%
2013-09-30 $0.01B $0.00B 17.67%
2013-06-30 $0.02B $0.00B 21.45%
2013-03-31 $0.01B $0.00B 17.67%
2012-12-31 $0.02B $0.32B 22.71%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.186B $0.644B
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.395B 6.36
Dr Reddy's Laboratories (RDY) India $11.853B 22.68
BridgeBio Pharma (BBIO) United States $4.426B 0.00
Bausch Health Cos (BHC) Canada $2.931B 2.13
Supernus Pharmaceuticals (SUPN) United States $2.000B 27.23
Taysha Gene Therapies (TSHA) United States $0.506B 35.29
Personalis (PSNL) United States $0.245B 0.00
Assembly Biosciences (ASMB) United States $0.096B 0.00
Sol-Gel Technologies (SLGL) Israel $0.015B 0.00
Evoke Pharma (EVOK) United States $0.006B 0.00
Teligent (TLGT) United States $0.000B 0.00